当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2007年第3期
编号:11385926
重组人黑色素瘤抗原MAGE3/HSP70融合蛋白工程菌的高密度发酵及其免疫学活性
http://www.100md.com 《第四军医大学学报》 2007年第3期
黑色素瘤抗原;发酵;大肠杆菌,,黑色素瘤抗原;发酵;大肠杆菌,0引言,1材料和方法,2结果,3讨论,【参考文献】
     High celldensity fermentation of engineered E.coli and antitumor immunity of recombinant human MAGE3/HSP70 in vivo

    HU PeiZhen,LU Fan,WANG XiaoGong,LI Xia,SI ShaoYan,HUANG Yang,MA Bin,ZHANG XiuMin,SUI YanFang

    Department of Pathology, Xijing Hospital, Department of Molecular Biology and Biochemistry, School of Basic Medicine, Fourth Military Medical University,Xi’an 710033, China

    【Abstract】 AIM: To realize high celldensity fermentation of MAGE3/HSP70 engineered E.coli,and to evaluate the antitumor immunity of MAGE3/HSP70 fusion protein in vivo. METHODS: High celldensity fermentation of MAGE3/HSP70 enginered E. coli was carried out with constant soluble oxygen and continuous cultivation in selfcontrol fermentor. The mouse was immunized by purified MAGE3/HSP70 fusion protein in E.coli, and the antitumor immunity was detected by ELISPOT and LDH release assay. RESULTS: High celldensity fermentation of MAGE3/HSP70 engineered E.coli was successful, and the expression of MAGE3/HSP70 in fermented bacterial was the same as the flask culture. The results of ELISPOT and LDH release assay showed that MAGE3/HSP70 generated tumor specific cytotoxic T lymphocyte (CTL) to damage tumor cel1. CONCLUSION: High celldensity fermentation of MAGE3/HSP70 engineered E.coli was realized and MAGE3/HSP70 fusion protein can generate specific CTL to kill tumor cel1. ......

您现在查看是摘要页,全文长 15095 字符